Study for corneal disease and corneal thinning
Part of Eyes & vision clinical trials.
This study looks at people with corneal disease, especially corneal thinning that can change how the eye focuses light. It may help researchers understand treatments and care plans for these conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a corneal disease (a problem affecting the clear front window of the eye)
- You have corneal ectasia (corneal thinning or bulging that can affect vision)
- You must be 18 years old or older
- You cannot be pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special “Brillouin” microscope scan can spot corneal ectasia and related cornea conditions. It may help doctors diagnose problems earlier and better sort out who needs closer eye care.
This Phase 2 study tests how safe and well a corneal cross-linking device (called PXL-Platinum 330) works for people with corneal ectasia (a thinning/steepening of the cornea). If you qualify, the goal is to help stop or slow further worsening of your cornea shape and improve eye stability.
This study tests whether a special eye scan called OCT can better identify causes of irregular cornea shape. Results may help doctors sort out different cornea problems so treatment choices, like certain procedures, can be more targeted.
This trial tests a surgery called CTAK for people with keratoconus or corneal ectasia. It aims to see if the surgery can help improve vision by reshaping the cornea.
This study tests a procedure called Xenia corneal lenticule in people with severe keratoconus or severe post-LASIK corneal thinning who want to avoid a corneal transplant. It aims to improve vision while checking safety and how well the new procedure works over time.
This trial uses special eye imaging to measure how your cornea (the eye’s clear front surface) changes, and then builds a personalized model for you. It may help doctors plan safer, more tailored treatment for keratoconus—especially if you’re considering LASIK.
Hear when a new Corneal Ectasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.